Double-Blind, parallel-group comparison, investigators initiated phase II clinical trial of IDEC-C2B8 (Rituximab) in patients with Systemic Sclerosis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Rituximab (Primary)
- Indications Systemic scleroderma
- Focus Therapeutic Use
- 03 Dec 2018 Last checked against University Hospital Medical Information Network - Japan record.
- 29 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Jan 2018 Status changed from not yet recruiting to recruiting.